Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Tempest Therapeutics, Inc. TPST

Set alert

Price alert · TPST

All alert types
0.47 USD 0.00 -0.59%

As of Nov 3, 1:37 PM ET

Bid
0.46 × 1
Ask
0.47 × 1
0.4638 Day range 0.4999
0.4638 52-week range 10.33
YTD
-83.65%
1 year
-95.32%
Open
0.4965
Prev close
0.472
Mkt cap
9.33M
Vol
102.78K
Avg vol
2.58M
EPS
-3.93
P/E
0.00
Div yield
0.00%
More statistics
Low
0.4638
High
0.4999
Forward P/E
-0.61
Beta
-2.78
Short ratio
0.39
Inst. own
23.02%
Dividend
0.00
Ex-div date
50-d avg
0.95482
200-d avg
2.12
1y target
18.75

6M chart

Chart tools
Interval
1m5m15m30m

Signals (30)
NameDateAgo
MACD: Buy SignalNov 3, 20264 hours ago
RSI: OversoldOct 30, 20264 days ago
RSI: OversoldOct 21, 20261 week ago
MACD: Sell SignalSep 24, 20261 month ago
SMA: BearishSep 23, 20261 month ago
MACD: Buy SignalSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BearishSep 17, 20261 month ago
SMA: BullishSep 16, 20261 month ago
RSI: OversoldSep 15, 20261 month ago
SMA: BearishSep 8, 20261 month ago
MACD: Sell SignalSep 3, 20262 months ago
SMA: BullishAug 24, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 17, 20262 months ago
SMA: BearishAug 14, 20262 months ago
SMA: BullishAug 11, 20262 months ago
RSI: OversoldJul 30, 20263 months ago
RSI: OversoldJul 28, 20263 months ago
MACD: Buy SignalJun 29, 20264 months ago

Newest 20 of 30.

Analyst view

Consensus: buy

Buy
Price target (mean) 18.75 +3896.2% upside
Target (low)
5.00
Target (mean)
18.75
Target (high)
47.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 6
  • 2 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TPST analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.245-0.30 – -0.19-0.34+27.9%00.0%4
Next quarter-0.28-0.31 – -0.25-0.36+22.2%00.0%2
Current year-1.32-1.45 – -1.18-1.91+31.1%00.0%4
Next year-1.10-1.45 – -0.87-1.32+16.4%00.0%4

Upgrades and downgrades

The latest rating changes

TPST analyst upgrades and downgrades
DateFirmActionFromTo
Nov 13, 2024Piper SandlerMaintainedOverweightOverweight
Nov 13, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 21, 2024Piper SandlerReiteratedOverweightOverweight
Jun 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 13, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 14, 2024ScotiabankInitiated—Sector Outperform
Mar 13, 2024ScotiabankInitiated—Sector Outperform
Mar 12, 2024HC Wainwright & Co.MaintainedBuyBuy
Feb 8, 2024JefferiesInitiated—Buy
Oct 11, 2023HC Wainwright & Co.MaintainedBuyBuy
Aug 11, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 5, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 30, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 11, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 28, 2023Ladenburg ThalmannMaintained—Buy
Mar 23, 2023Piper SandlerMaintained—Overweight
Mar 23, 2023HC Wainwright & Co.Reiterated—Buy
Feb 8, 2023HC Wainwright & Co.Maintained—Buy
Sep 15, 2022Ladenburg ThalmannInitiated—Buy
May 16, 2022HC Wainwright & Co.Maintained—Buy
Oct 21, 2021William BlairInitiated—Outperform
Jul 13, 2021HC Wainwright & Co.Initiated—Buy
Jul 6, 2021Piper SandlerInitiated—Overweight